AstraZeneca

  www.astrazeneca.com
  www.astrazeneca.com

AstraZeneca Jobs & Careers in Phoenix, AZ

Hiring? Post a Job
1 job opening Back to all jobs

Show:  All Results Last 7 Days
10 days ago

Diabetes Sales Specialist - D3 - Phoenix South, AZ

AstraZeneca Phoenix, AZ

AstraZeneca


AstraZeneca Reviews

476 Reviews
3.3
476 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
AstraZeneca Executive Director, CEO Pascal Soriot
Pascal Soriot
133 Ratings
  1. 1 person found this helpful  

    Field Sales at AstraZeneca

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Career Opportunities
    Current Employee - Anonymous Employee in Phoenix, AZ
    Current Employee - Anonymous Employee in Phoenix, AZ

    I have been working at AstraZeneca

    Pros

    Compensation is above average, Bonus is based on national average not on goal attainment so there is the potential for earning big bonuses during a down year. The company has some potential block busters in their pipeline. Career Ladder II and III promotions are fairly plentiful. The company offers stock options to the top 10% of the sales force.

    Cons

    Nexium is about to go generic and there is another large layoff looming on the horizon. The sales force is populated with disgruntled tenured reps who remember when budgets were unlimited and new reps eager to work for big pharma. Certain areas of the country have poor work environments while others are supportive. There is a lot of pressure to perform but little guidance on how to achieve that goal since leadership is out of touch with the field. Leadership understand the problems but there is no consensus on a solution. There are many different things being tried but it can appear to be very unorganized.

    Advice to ManagementAdvice

    My advice to leadership would be to devise a plan and stick with it for at least a year. It is confusing to change strategies every three months. That is the only way to know if the plan is working or not. Big pharma became big pharma because they had campaigns they stuck to over long periods of time. The mid-year tweaks were the addition of clinical studies that could be used by field sales to provide addition points of differentiation. AstraZeneca does not provide enough clinical studies to the field.

    No opinion of CEO

Work at AstraZeneca? Share Your Experiences

AstraZeneca

 
Click to Rate
or